Itraconazole is an antifungal medication that is commonly used to treat a variety of fungal infections. The 150 mg vaginal suppository formulation of itraconazole is designed to combat fungal infections within the vaginal area, such as vulvovaginal candidiasis. This solid dosage form is specifically created for insertion into the vagina, where it dissolves or melts, releasing the itraconazole to exert its local antifungal effects directly at the site of infection. This targeted approach can lead to higher concentrations of the medication in the affected area, potentially resulting in more effective treatment with fewer systemic side effects.

The itraconazole vaginal suppository works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. By disrupting the cell membrane, itraconazole impairs the growth and replication of the fungal cells, thereby alleviating the infection. The 150 mg dose has been chosen to provide an effective concentration of the medication while minimizing the risk of systemic absorption and side effects. This dosage form is particularly beneficial for patients who may not tolerate oral itraconazole due to gastrointestinal side effects or those who have difficulty achieving adequate drug levels at the site of infection with oral therapy.

Patients using the itraconazole vaginal suppository should be aware that the medication is intended for vaginal use only and should not be taken by mouth or inserted into any other body cavity. It is important to follow the prescribed dosing regimen and complete the full course of treatment, even if symptoms improve, to ensure the infection is fully eradicated and to prevent the development of drug-resistant fungal strains. As with any medication, there may be potential side effects, and patients should be advised to contact their healthcare provider if they experience any unusual symptoms or if their condition does not improve.

Prescribers considering itraconazole vaginal suppositories for their patients should take into account the patient's medical history, including any known hypersensitivity to itraconazole or other azole antifungal agents. It is also important to consider potential drug interactions, as itraconazole can interact with a wide range of medications. Monitoring for therapeutic effectiveness and side effects is recommended, and prescribers should provide patients with clear instructions on how to use the medication correctly.

At Bayview Pharmacy, we are committed to providing high-quality compounded medications tailored to the specific needs of our patients. Our team of knowledgeable compounding pharmacists is available to answer any questions and provide additional information about itraconazole vaginal suppositories or any other compounded formulations. If you have any questions or require further assistance, please do not hesitate to reach out to us.

Itraconazole is an antifungal medication that works by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes. By disrupting the cell membrane, itraconazole effectively treats fungal infections. When formulated as a 150 mg vaginal suppository, itraconazole is used for the local treatment of vaginal fungal infections, such as vulvovaginal candidiasis. While the primary action is local, some systemic absorption can occur.

When considering drug interactions, it is important to note that itraconazole is a potent inhibitor of the cytochrome P450 3A4 (CYP3A4) enzyme. This means that it can interact with a wide range of medications that are metabolized by this pathway. Concurrent use of itraconazole with drugs that are substrates of CYP3A4 can result in increased plasma concentrations of these drugs, potentially leading to toxicity. Examples include certain statins, calcium channel blockers, and immunosuppressants such as cyclosporine and tacrolimus.

Additionally, itraconazole's absorption can be affected by drugs that alter gastric acidity, as it requires an acidic environment for optimal absorption. Antacids, H2 antagonists, and proton pump inhibitors can decrease the absorption of itraconazole, potentially reducing its efficacy. Patients should be advised to take itraconazole with an acidic beverage like cola if they are using medications that reduce stomach acidity.

Drugs that induce CYP3A4, such as rifampin, carbamazepine, and phenytoin, can significantly decrease the plasma concentrations of itraconazole, potentially leading to therapeutic failure. Conversely, itraconazole can increase the plasma concentrations of drugs metabolized by CYP3A4, which may necessitate dosage adjustments of the concomitant medication and careful monitoring for adverse effects.

It is also important to avoid the concurrent use of itraconazole with certain drugs that can prolong the QT interval, as itraconazole itself can cause QT prolongation. This combination can increase the risk of serious cardiac arrhythmias such as torsades de pointes. Drugs to be cautious about include certain antiarrhythmics, antipsychotics, and antibiotics.

Patients should be counseled to inform their healthcare providers of all medications they are taking, including over-the-counter drugs and herbal supplements, as these can also interact with itraconazole. Alcohol should be avoided as it can exacerbate the hepatotoxic effects of itraconazole.

For prescribers, it is crucial to review the patient's medication profile for potential drug interactions before prescribing itraconazole vaginal suppositories. Monitoring for signs and symptoms of drug interactions, adjusting doses, and ordering appropriate laboratory tests when necessary are important steps in managing these interactions.

If you have any questions or require further clarification regarding drug interactions with itraconazole vaginal suppositories, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the necessary support and guidance to ensure the safe and effective use of this formulation.

Itraconazole is an antifungal medication that belongs to a class of drugs known as triazoles. It works by inhibiting the synthesis of ergosterol, a critical component of fungal cell membranes. Without ergosterol, the cell membrane becomes weak and permeable, leading to the leakage of cellular contents and ultimately the death of the fungal cell. This mechanism of action makes itraconazole effective against a broad spectrum of fungi, including those responsible for various vaginal yeast infections such as Candida species.

The itraconazole 150 mg vaginal suppository is a solid dosage form designed for insertion into the vagina. Once inserted, the suppository base, typically made from substances like cocoa butter or a synthetic analogue, melts or dissolves at body temperature, releasing the itraconazole in a localized manner. This allows the medication to act directly on the site of infection, leading to higher concentrations of the drug in the vaginal tissue compared to oral administration. This targeted delivery can result in fewer systemic side effects and improved therapeutic outcomes for vaginal fungal infections.

By treating the infection locally, itraconazole vaginal suppositories can alleviate symptoms such as itching, burning, and discharge associated with yeast infections. The direct application to the affected area enhances the medication's effectiveness and can lead to a quicker resolution of the infection. Additionally, the use of a suppository bypasses the gastrointestinal tract, which can be beneficial for patients who have difficulty swallowing pills or who may experience gastrointestinal side effects from oral itraconazole.

It is important for patients and prescribers to understand that while itraconazole vaginal suppositories are designed for local treatment of fungal infections, some absorption into the bloodstream may occur. This systemic absorption can contribute to the overall antifungal activity but is generally minimal with this form of administration. Patients should be advised to follow the prescribed dosing regimen and to complete the full course of treatment even if symptoms improve, to ensure the infection is fully eradicated and to reduce the risk of recurrence.

For any questions or concerns regarding the itraconazole 150 mg vaginal suppository, or to discuss whether this formulation is appropriate for your specific condition, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to effectively manage your health.

Itraconazole is an antifungal agent commonly used to treat various fungal infections. This particular formulation, Itraconazole 150 mg as a vaginal suppository, is specifically designed to address localized fungal infections within the vaginal area, such as vulvovaginal candidiasis. The suppository form permits the drug to exert direct action at the site of infection, reducing systemic absorption and potential side effects. The high concentration of the drug in the vaginal tissue can offer an intensive treatment, targeting the fungal organisms causing the infection.

Beyond its primary indication for treating vaginal yeast infections, itraconazole vaginal suppositories could potentially be used in other scenarios. For example, although not typically the first line of treatment, in cases where a patient might be non-responsive or allergic to the standard antifungal medications for vulvovaginal candidiasis, itraconazole suppositories could provide an alternative. Occasionally, it may be considered for off-label uses such as for the prophylaxis of recurrent infections in women with a history of frequent vulvovaginal candidiasis, especially when oral or topical treatment options are not preferred or contraindicated.

While the suppository form of itraconazole is predominantly intended for vaginal use, there could also be considerations for use in treating localized fungal infections in other areas accessible by suppository administration, such as the rectal cavity; however, this would be less common and should only be pursued under the guidance of a healthcare professional experienced in the treatment of such infections. The mode of delivery of the drug via suppository allows for high local drug concentrations, which can be advantageous when treating infections in a specific area.

It is important to note that appropriate use of itraconazole vaginal suppositories should be based on culture and sensitivity reports of the infective organism from the patient. Additionally, prescribers should be aware of the potential for interactions between itraconazole and other medications the patient might be taking, given that itraconazole is a potent inhibitor of the cytochrome P450 (CYP3A4) enzyme system. Patients should be counselled on how to insert the suppository properly and to recognize potential side effects that warrant medical attention, such as irritation or allergic reactions.

This formulation may not be appropriate for all patient populations, including those with liver dysfunction or those who are pregnant or breastfeeding. Therefore, clinical judgment and individualized patient assessments are crucial when considering the use of itraconazole vaginal suppositories for any indication apart from its primary use. If you have any questions or would like more information on appropriate uses for itraconazole vaginal suppositories, please reach out to us at Bayview Pharmacy. Our team is here to support healthcare providers and patients by providing education and personalized guidance on our compounded medications.